Newsroom | 5412 results

LIBERTYVILLE, Ill.--(BUSINESS WIRE)--Dr. Mikin V. Patel and Dr. Osman Ahmed have co-founded the Joint & Vascular Institute. Both doctors specialize in performing minimally invasive imaging-guided procedures to treat a multitude of diseases and health conditions, many of which once required open surgery. Dr. Patel completed his diagnostic radiology residency at the University of Chicago Medical Center and a fellowship in Vascular and Interventional Radiology at Northwestern McGaw Medical Cen...

LONDON & MELBOURNE, Australia & PHOENIX--(BUSINESS WIRE)--Avata Biosciences Holdings Ltd (‘Avata’), a pioneering biopharmaceutical company specializing in neuroscience drug discovery and clinical development, today announced it has signed a co-development and licensing agreement with Oceanus Bio, Inc. for the exclusive rights to AVAT-021 and AVAT-022 in Japan and Asia, except in China and India. The agreement comprises $95m in co-development contributions, regulatory and sales milestone payment...

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--BoldAge PACE, a rapidly growing provider of Programs of All-Inclusive Care for the Elderly (PACE), will officially celebrate the grand opening of its North Charleston center on Wednesday, June 18, from 12:00 to 2:00 pm, with a ribbon cutting scheduled for 12:15 pm. The new center is located at 2801 Ashley Phosphate Rd. North Charleston SC 29418. The event marks the public unveiling of the innovative care center, which began serving older adults in North...

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today provided a corporate update. “It is especially gratifying that at a time when we are advancing our clinical pipeline programs, with our lead program CYB003 in Phase 3 development, the path toward approval and eventua...

CHICAGO--(BUSINESS WIRE)--Cresco Labs Announces Change of Auditor...

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will participate in a virtual fireside chat at the H.C. Wainwright 6th Annual Neuro Perspectives Conference, taking place June 16-17, 2025. Mr. Drysdale’...

SAN FRANCISCO--(BUSINESS WIRE)--SoundHealth, a medical technology company harnessing the power of artificial intelligence and medical science to improve patient outcomes, announced it received United States Food and Drug Administration (FDA) approval for pediatric use of its groundbreaking SONU Band. SONU is the world’s first FDA De Novo authorized, AI-enabled, wearable medical device for at-home treatment of moderate to severe nasal congestion due to allergic and non-allergic rhinitis. This ex...

NEW YORK--(BUSINESS WIRE)--Wisp, the largest pure play women's telehealth company in the U.S. focused on providing sexual and reproductive health solutions to more than 1.5 million customers, today announced the appointment of Jennifer Peña, MD, as the company’s Chief Medical Officer. Dr. Peña will have a crucial role in driving Wisp’s commitment to being the one-stop-shop for all women’s health needs, as the company continues to scale new and existing offerings. As CMO, Dr. Peña will spearhead...

LOS ANGELES--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, shares positive results from a clinical study published in the peer-reviewed journal Aging Cell, by a team led by Masaya Koshizaka, M.D., Ph.D., Associate Professor, and Koutaro Yokote, M.D., Ph.D., MBA, President of Chiba University, both of the Center for Preventive Medical Sciences, Chib...

COLUMBUS, Ohio--(BUSINESS WIRE)--AndHealth Dermatology has welcomed Dr. Drew Kurtzman to its practice starting in May 2025. Dr. Kurtzman is a renowned board-certified dermatologist from Kentucky who will now see patients in Kentucky and Ohio as a part of AndHealth Dermatology. Appointments can be scheduled by calling 614-398-0582, by emailing appointments@andhealth.com, or by visiting DrDrewKurtzmanDermatologist.com. Dr. Kurtzman brings a deep commitment to providing compassionate, expert care...